Mary Rojas

Mary Rojas is a Regulatory Affairs professional with over 12 years of experience in the Pharmaceutical and Biotechnology industries. Currently serving as the Associate Director of Regulatory Affairs CMC at Seagen, they manage the CMC aspects of clinical portfolios to ensure high-quality regulatory submissions. Previously, Mary achieved earlier BLA approval in China at Bayer and expedited NDA launches at Pfizer. Their educational background includes a Bachelor’s in Pharmacy from Universidad Central de Venezuela and a Regulatory Affairs certificate from the University of California, Berkeley.